About Arcturus Therapeutics
Arcturus Therapeutics is a company based in San Diego (United States) founded in 2013.. Arcturus Therapeutics has raised $1.3 million across 7 funding rounds from investors including Cystic Fibrosis Foundation. The company has 176 employees as of December 31, 2024. Arcturus Therapeutics operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Alnylam and Rhythm Pharmaceuticals, among others.
- Headquarter San Diego, United States
- Employees 176 as on 31 Dec, 2024
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Arcturus Therapeutics Holdings Inc.
-
Annual Revenue
$138.39 M-12.27as on Dec 31, 2024
-
Net Profit
$-80.94 M-172.3as on Dec 31, 2024
-
EBITDA
$-35.58 M-2877.57as on Dec 31, 2024
-
Total Equity Funding
$1.3 M (USD)
in 7 rounds
-
Latest Funding Round
- Investors
-
Employee Count
176
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Arcturus Therapeutics
Arcturus Therapeutics is a publicly listed company on the NASDAQ with ticker symbol ARCT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Arcturus Therapeutics
Arcturus Therapeutics has successfully raised a total of $1.3M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Last Round
-
First Round
First Round
(05 Apr 2013)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Grant - Arcturus Therapeutics | Valuation |
investors |
|
| Jan, 2018 | Amount | Post-IPO - Arcturus Therapeutics | Valuation |
investors |
|
| May, 2017 | Amount | Grant - Arcturus Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Arcturus Therapeutics
Arcturus Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Cystic Fibrosis Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Research funding and support for cystic fibrosis patients are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Arcturus Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Arcturus Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Arcturus Therapeutics Comparisons
Competitors of Arcturus Therapeutics
Arcturus Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Alnylam and Rhythm Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Arcturus Therapeutics
Frequently Asked Questions about Arcturus Therapeutics
When was Arcturus Therapeutics founded?
Arcturus Therapeutics was founded in 2013.
Where is Arcturus Therapeutics located?
Arcturus Therapeutics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Arcturus Therapeutics a funded company?
Arcturus Therapeutics is a funded company, having raised a total of $1.3M across 7 funding rounds to date. The company's 1st funding round was a Grant of $3M, raised on Apr 05, 2013.
How many employees does Arcturus Therapeutics have?
As of Dec 31, 2024, the latest employee count at Arcturus Therapeutics is 176.
What is the annual revenue of Arcturus Therapeutics?
Annual revenue of Arcturus Therapeutics is $138.39M as on Dec 31, 2024.
What does Arcturus Therapeutics do?
Arcturus Therapeutics was founded in 2013 and is based in San Diego, United States. RNAi technologies are developed for addressing rare orphan diseases within the biotechnology sector. Proprietary LUNAR lipid-mediated delivery and STARR mRNA Technology are applied to create RNA medicines targeting rare and infectious diseases. The lead candidate, LUNAR-OTC, is directed toward ornithine transcarbamylase deficiency.
Who are the top competitors of Arcturus Therapeutics?
Arcturus Therapeutics's top competitors include Moderna, Spark Therapeutics and BridgeBio.
Is Arcturus Therapeutics publicly traded?
Yes, Arcturus Therapeutics is publicly traded on NASDAQ under the ticker symbol ARCT.
Who are Arcturus Therapeutics's investors?
Arcturus Therapeutics has 1 investor. Key investors include Cystic Fibrosis Foundation.
What is Arcturus Therapeutics's ticker symbol?
The ticker symbol of Arcturus Therapeutics is ARCT on NASDAQ.